• Work with local people to build a global community of cities, institutions, and partners
  • Empower that community with the tools, processes, and structures to improve cancer care locally.
  • Share what we learn at the city level with the rest of the world so that local innovation can reap global benefits.

Our Partners

C/Can is committed to building a global community of multi-sector stakeholders. These diverse actors provide expertise and in-kind and financial support during all phases of the initiative’s design, development, and implementation at global, regional, and city levels.

Our Team

Top Team Image

Our Board

Name

Institution

Country

Sanchia Aranda (Board Chair)

Cancer Council Australia

Australia

Raul Doria (Vice Chair)

Grupo San Roque

Paraguay

Zipporah Ali

Kenya Hospices and Palliative Care Association (KEHPCA)

Kenya

Thomas Cueni

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Switzerland

Mary Gospodarowicz

Princess Margaret Princess Centre (PMCC)

Canada

Yin Yin Htun (Rose)

Shwe Yaung Hnin Si Cancer Foundation Pun Hlaing Siloam Hospital

Myanmar

Kolleen Kennedy

Varian

United States

Mark Middleton

Icon Group

Australia

Adolfo Rubinstein

National Ministry of Health

Argentina

Luis Miguel Castilla Rubio

Inter-American Development Bank

United States

Jörg-Michael Rupp

Roche Pharma International

Switzerland

 

Our Approach

There are 18.1 million new cancer cases and over 9.6 million cancer deaths worldwide each year, and these numbers are increasing drastically. With 54% of the world’s population living in cities, we believe cities are uniquely positioned to drive sustainable innovation in the delivery of health services to large populations.

Despite recent improvements in cancer care worldwide, access to surgery, radiotherapy, and essential oncology medicines remains an enormous challenge in low- and middle-income countries. These issues are compounded by a lack of human resources specialized in cancer care across all regions and income settings.

To address this global challenge, C/Can has developed a “City Engagement Process” that outlines support for participating cities over a two-year period, during which they identify, plan, and implement solutions to major gaps in quality cancer treatment and care—from diagnosis to palliative and supportive care.

Implementation Infographics

The "City Engagement Process" is shaped around the following steps:

  • Identify and engage all relevant stakeholders in the delivery of cancer care in the city
  • Undertake a comprehensive, city-wide, data-driven needs assessment to identify current gaps and priorities
  • Develop an activity plan based on the needs assessment
  • Identify appropriate channels for technical assistance; partnerships and collaboration, both locally and internationally; one-off investments; and/or longer-term financing solutions to support implementation of the activity plan
  • Develop a framework to monitor and evaluate progress and impact and support learning

While cities take the lead in developing cancer treatment solutions, they work closely with C/Can’s multi-sector community of global and local partners, who provide technical assistance through each phase of the initiative. C/Can recognizes that each city is unique in its social, economic, and environmental development, which means there is no one-size-fits-all city cancer treatment solution.

 
Slide
Slide
Slide

Resources